» Articles » PMID: 21960561

Focused Ultrasound-mediated Drug Delivery from Microbubbles Reduces Drug Dose Necessary for Therapeutic Effect on Neointima Formation--brief Report

Overview
Date 2011 Oct 1
PMID 21960561
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We hypothesized that (1) neointima formation in a rat carotid balloon injury model could be reduced in vivo following targeted ultrasound delivery of rapamycin microbubbles (RMBs), and (2) the addition of dual-mode ultrasound decreases the total amount of drug needed to reduce neointima formation.

Methods And Results: Balloon injury was performed in rat carotids to induce neointima formation. High or low doses of RMBs were injected intravenously and ruptured at the site of injury with ultrasound. Compared with nontreated injured arteries, neointima formation was reduced by 0% and 35.9% with 10(8) RMBs and by 28.7% and 34.9% in arteries treated with 10(9) RMBs with and without ultrasound, respectively.

Conclusions: Without ultrasound, 10-fold higher concentrations of RMBs were needed to reduce neointima formation by at least 28%, whereas 10(8) RMBs combined with ultrasound were sufficient to achieve the same therapeutic effect, demonstrating that this technology may have promise for localized potent drug therapy.

Citing Articles

Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application.

Jeong Y, Park J, Khang D Int J Nanomedicine. 2024; 19:11767-11788.

PMID: 39553460 PMC: 11566213. DOI: 10.2147/IJN.S496028.


Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis.

Zong Q, He C, Long B, Huang Q, Chen Y, Li Y Biomedicines. 2024; 12(7).

PMID: 39062077 PMC: 11275173. DOI: 10.3390/biomedicines12071504.


Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.

Lim S, Yee G, Khang D Int J Nanomedicine. 2024; 19:2529-2552.

PMID: 38505170 PMC: 10949308. DOI: 10.2147/IJN.S450853.


Ultrasound and Microbubbles for Targeted Drug Delivery to the Lung Endothelium in ARDS: Cellular Mechanisms and Therapeutic Opportunities.

Sanwal R, Joshi K, Ditmans M, Tsai S, Lee W Biomedicines. 2021; 9(7).

PMID: 34356867 PMC: 8301318. DOI: 10.3390/biomedicines9070803.


Preclinical study to improve microbubble-mediated drug delivery in cancer using an ultrasonic probe with an interchangeable acoustic lens.

Lee S, Jeon H, Shim S, Im M, Kim J, Kim J Sci Rep. 2021; 11(1):12654.

PMID: 34135427 PMC: 8209130. DOI: 10.1038/s41598-021-92097-z.


References
1.
Mahalati K, Kahan B . Clinical pharmacokinetics of sirolimus. Clin Pharmacokinet. 2001; 40(8):573-85. DOI: 10.2165/00003088-200140080-00002. View

2.
Dayton P, Klibanov A, Brandenburger G, Ferrara K . Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol. 1999; 25(8):1195-201. DOI: 10.1016/s0301-5629(99)00062-9. View

3.
Ferrara K, Pollard R, Borden M . Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007; 9:415-47. DOI: 10.1146/annurev.bioeng.8.061505.095852. View

4.
Phillips L, Klibanov A, Wamhoff B, Hossack J . Localized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation. J Control Release. 2011; 154(1):42-9. PMC: 3148278. DOI: 10.1016/j.jconrel.2011.04.020. View

5.
Phillips L, Klibanov A, Bowles D, Ragosta M, Hossack J, Wamhoff B . Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles. J Vasc Res. 2009; 47(3):270-4. PMC: 2865392. DOI: 10.1159/000258905. View